Vor Biopharma, Inc. (VOR)
12.13
+1.80
(+17.42%)
USD |
NASDAQ |
Dec 11, 16:00
12.00
-0.13
(-1.07%)
After-Hours: 05:00
Vor Biopharma Total Liabilities (Quarterly): 2.402B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Outset Medical, Inc. | 134.89M |
| Salarius Pharmaceuticals, Inc. | 1.849M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
| Theriva Biologics, Inc. | 24.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 176.24M |
| Shareholders Equity (Quarterly) | -2.225B |
| Debt to Equity Ratio | -0.0014 |
| Current Ratio | 9.156 |
| Net Debt Paydown Yield | 1.85% |